SCHEMBL5437662

SCHEMBL5437662

c1ncc2nsnc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29355369 0.70 EGFR (0.34)
SCHEMBL3292267 0.69 PIK3CG (0.47)
Potassium SCHEMBL29619940 0.68 EGFR (0.33)
Hydrogen Sulfide SCHEMBL29184284 0.68 EGFR (0.33)
SCHEMBL27705809 0.68 EGFR (0.33)
Phosphine SCHEMBL3090397 0.68 CHRNB4 (0.33)
SCHEMBL28134927 0.68 EGFR (0.33)
SCHEMBL30826370 0.68 EGFR (0.33)
SCHEMBL6120084 0.68 EGFR (0.33)
Ammonia Solution, Strong SCHEMBL27506828 0.68 EGFR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
CN-110740996-B Covalent small molecule DCN1 inhibitors and methods of treatment using the same 密执安大学评议会 2024-01-09 CN disclosed
EP-3609876-B1 COVALENT SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME UNIV MICHIGAN REGENTS (US) 2022-03-30 EP disclosed
US-20200109167-A1 SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME UNIV MICHIGAN REGENTS (US) 2020-04-09 US disclosed
EP-3609876-A1 COVALENT SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME The Regents of The University of Michigan (US) 2020-02-19 EP disclosed
EP-3601245-A1 SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME The Regents of The University of Michigan (US) 2020-02-05 EP disclosed
WO-2018191199-A1 COVALENT SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-10-18 WO disclosed
US-20180289677-A1 Covalent Small Molecule DCN1 Inhibitors and Therapeutic Methods Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2018-10-11 US disclosed
WO-2018183411-A1 SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-10-04 WO disclosed
WO-2014086453-A1 AZAHETEROBICYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2014-06-12 WO disclosed
US-20070027156-A1 Crf antagonists and heterobicyclic compounds ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-01 US disclosed
US-20070027156-A1 Crf antagonists and heterobicyclic compounds ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-01 US disclosed
US-20070027156-A1 Crf antagonists and heterobicyclic compounds ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-01 US disclosed
EP-1666468-A1 CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS ONO PHARMACEUTICAL CO., LTD. (JP) 2006-06-07 EP disclosed
EP-0349239-B1 Condensed pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE FRENCH LAB (GB) 1994-03-16 EP disclosed
US-5075310-A PYRIMIDONE DERIVATIVES AS BRONCHODILATORS SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-24 US disclosed
EP-0349239-A2 Condensed pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-03 EP disclosed